A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.
J Med Chem
; 58(21): 8713-22, 2015 Nov 12.
Article
in En
| MEDLINE
| ID: mdl-26502160
ABSTRACT
Toward improving pharmacokinetics, in vivo efficacy, and selectivity over hERG, structure-activity relationship studies around the central core of antimalarial imidazopyridazines were conducted. This study led to the identification of potent pyrazolopyridines, which showed good in vivo efficacy and pharmacokinetics profiles. The lead compounds also proved to be very potent in the parasite liver and gametocyte stages, which makes them of high interest.
Full text:
1
Collection:
01-internacional
Health context:
3_ND
Database:
MEDLINE
Main subject:
Plasmodium berghei
/
Plasmodium falciparum
/
Pyrazoles
/
Pyridines
/
Malaria
/
Antimalarials
Limits:
Animals
/
Humans
Language:
En
Journal:
J Med Chem
Year:
2015
Document type:
Article